iifl-logo
  • testing
  • |

iifl-logo

Gland Pharma Ltd Board Meeting

1,664.7
(0.99%)
Jun 10, 2025|12:00:00 AM

Gland Pharma CORPORATE ACTIONS

02/07/2024calendar-icon
02/07/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting20 May 20256 May 2025
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025 and recommend the payment of Final Dividend for FY 2024-25 Outcome of Board Meeting - May 20, 2025 (As per BSE Announcement Dated on 20/05/2025)
Board Meeting26 Feb 202526 Feb 2025
Outcome of Board Meeting - 26th February 2025
Board Meeting3 Feb 202516 Jan 2025
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve Unaudited financial results for the quarter and nine months ended 31.12.2024 Unaudited Financial Results for the Quarter ended December 31, 2024 (As Per BSE Announcement Dated on: 03/02/2025)
Board Meeting4 Nov 202422 Oct 2024
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2024 inter alia to consider and approve Unaudited Financial results for the quarter and Half year ended September 30 2024 Appointment of Ms. Wei Huang as Additional Director w.e.f November 04, 2024 (As per BSE Announcement Dated on 04/11/2024)
Board Meeting6 Aug 202419 Jul 2024
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Un-Audited Financial Results for the Quarter ended June 30 2024 Unaudited Financial Results for Q1 FY25 (As Per BSE Announcement dated on 06.08.2024)

Gland Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.